Aarti Pharmalabs Ltd. (AARTIPHARM): Aarti Pharmalabs Share Price Rises 5.74% Today on Rs 7,443.45 Cr Market Cap
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Aarti Pharmalabs Share Price rose today as the stock moved to Rs 867.95, up 5.74% from the previous close of Rs 820.85. The company’s market capitalisation stood at Rs 7,443.45 Cr, placing the move in a clearly measurable market context. The day’s range stretched from Rs 814.10 to Rs 870.65, while turnover was Rs 4.46 Cr. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Aarti Pharmalabs Share Price Today, the key question is how this rise fits with valuation, sector positioning and company fundamentals. In today’s Aarti Pharmalabs Stock News, Univest focuses on verified price action, relative valuation and the healthcare industry backdrop so investors can judge the move using facts rather than speculation.
Aarti Pharmalabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 867.95 |
| Previous Close | Rs 820.85 |
| Today's Move | Rs 47.1 (+5.74%) |
| Open | Rs 820 |
| High | Rs 870.65 |
| Low | Rs 814.1 |
| Turnover | Rs 4.46 crore |
| Market Capitalisation | Rs 7,443.45 crore |
| Market Cap Category | Mid Cap |
Aarti Pharmalabs Ltd. (AARTIPHARM) rose to Rs 867.95 from the previous close of Rs 820.85, a move of Rs 47.1 or 5.74%. The stock opened at Rs 820, reached a high of Rs 870.65, recorded a low of Rs 814.1.
Aarti Pharmalabs Share Price Today opened at Rs 820 and moved between Rs 814.10 and Rs 870.65 before closing at Rs 867.95. The stock added Rs 47.10 in one session, compared with the previous close of Rs 820.85. That makes Aarti Pharmalabs Share Price Rise a 5.74% move for the day. The day’s turnover of Rs 4.46 Cr provides the value traded in the session, while the movement kept the stock near the upper end of the day’s range. Univest notes the verified price update without assigning a cause, because the supplied data confirms the move but does not identify a company-specific trigger.
Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,443.45 crore |
| P/E Ratio | 34.92x |
| P/B Ratio | 3.4x |
| ROE | 8.5% |
| ROCE | 10.77% |
| EPS | Rs 23.51 |
| Book Value Per Share | Rs 241.54 |
| Dividend Yield | 0.43% |
Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 34.92x, P/B 3.4x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.
Aarti Pharmalabs Ltd. has a market capitalisation of Rs 7443.45 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.92x, P/B at 3.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.43%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.92x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 3.4x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 8.5% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 10.77% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 7,443.45 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 34.92x, which is above the benchmark median of 32.87x, a difference of +6.24%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.7%, a difference of -27.35%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.46%, a difference of -19.99%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 34.92x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 7,443.45 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Aarti Pharmalabs
- Aarti Pharmalabs Share Price rose 5.74% today to Rs 867.95.
- The stock added Rs 47.10 from the previous close of Rs 820.85.
- Market capitalisation stood at Rs 7,443.45 Cr in today’s session.
- P/E was 34.92, while P/B was 3.4 and dividend yield was 0.43%.
- ROE was 8.5 and ROCE was 10.77, both below the industry medians in the supplied benchmark.
About Aarti Pharmalabs
Aarti Pharmalabs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its listed equity context, valuation profile and benchmark placement, rather than through a detailed business segment breakdown. For readers tracking Aarti Pharmalabs Stock News and Aarti Pharmalabs Company News, the important point is that the business is evaluated within a large industry sample of 204 companies. The stock’s current market cap, earnings metrics and return ratios provide the clearest factual picture available in the supplied dataset. In Aarti Pharmalabs Stock Performance terms, today’s rise adds short-term visibility, while the underlying ratios show how the company compares with other listed healthcare names on earnings, book value and profitability. Univest uses this company overview to keep the analysis anchored in verified market data.
Track Aarti Pharmalabs Share Price on Univest
Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Aarti Pharmalabs Share Price on Univest for live price updates, fundamental ratios, sector context, shareholding pattern and 52-week levels in one place. Univest also helps readers follow Aarti Pharmalabs Share Price Today with market insights, company metrics and broader stock coverage. For users scanning Aarti Pharmalabs Latest News, the goal is simple: keep the data organised, factual and easy to review. Univest brings together the stock’s price action, valuation measures and industry comparison so that Aarti Pharmalabs Stock Analysis can be monitored without relying on fragmented updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Aarti Pharmalabs Share Price rise today?
Ans. Aarti Pharmalabs Share Price rose 5.74% today, but the supplied data does not identify a company-specific catalyst. The move is confirmed by the price data, previous close, and intraday range.
What is Aarti Pharmalabs Share Price today?
Ans. Aarti Pharmalabs Share Price today is Rs 867.95. It moved up from the previous close of Rs 820.85 and finished Rs 47.10 higher, making it one of the notable stock moves in the session.
How much did Aarti Pharmalabs stock gain today?
Ans. Aarti Pharmalabs stock gained Rs 47.10 today, which equals a 5.74% rise. The stock opened at Rs 820 and traded between Rs 814.10 and Rs 870.65 during the session. The previous close was Rs 820.85.
What is Aarti Pharmalabs market capitalisation?
Ans. Aarti Pharmalabs market capitalisation is Rs 7,443.45 Cr. That places the company above the industry median in the supplied healthcare benchmark, while still far below the largest listed peers in the sector.
What does Aarti Pharmalabs valuation show?
Ans. Aarti Pharmalabs Share Price trades at a P/E of 34.92 and a P/B of 3.4. These figures sit above the industry medians in the supplied benchmark, while ROE and ROCE remain below them.
How does Aarti Pharmalabs compare with peers?
Ans. Compared with peers like Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, Aarti Pharmalabs has a much smaller market cap and lower return ratios. Its P/E is below some peers and above others.
What are Aarti Pharmalabs earnings metrics?
Ans. Aarti Pharmalabs reports EPS of Rs 23.51, book value of Rs 241.54 and dividend yield of 0.43%. These numbers help frame earnings, accounting value and payout context for the stock.
Is Aarti Pharmalabs Share Price relevant for healthcare sector tracking?
Ans. Yes. Aarti Pharmalabs Share Price is relevant because the company sits in Healthcare and Pharmaceuticals & Drugs, with valuation and return ratios that can be compared directly with the supplied industry benchmark.
